Ignite Creation Date:
2024-05-05 @ 7:21 PM
Last Modification Date:
2024-10-26 @ 9:47 AM
Study NCT ID:
NCT00655837
Status:
COMPLETED
Last Update Posted:
2014-12-18
First Post:
2008-04-04
Brief Title:
Trial to Define the Safety and Tolerability of SGN-40 Rituximab and Gemcitabine in Patients With DLBCL
Sponsor:
Organization:
Seagen Inc